Lexeo Therapeutics, Inc.
LX2006
Friedreich Ataxia
Resolved
7days ago
Phase 1 readout · Jun 30, 2026
What's at stake
Phase 1 trial results for LX2006 in Friedreich Ataxia are due Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“SUNRISE-FA 2 Pivotal Study for Accelerated Approval SUNRISE-FA (Phase I/II) Long-Term Follow Up Ongoing SUNRISE-FA (Phase I/II) CLARITY-FA Natural History Study 2028 LX2006 for the Treatment of Friedreich Ataxia Cardiac complications are th”